VLP THERAPEUTICS LLC

9700 GREAT SENECA HWY, ROCKVILLE, Maryland, 20850, US

2-10

<$5 Million

View Employees in VLP THERAPEUTICS LLC
Real-Time AI Research
0 search queries left
FlashIntel GPT
Hello! I'm FlashIntel GPT, your personal AI search assistant. Feel free to ask me anything about VLP THERAPEUTICS LLC, and I'll do my best to assist you.
You

Tell me more about VLP THERAPEUTICS LLC?

FlashIntel GPT
VLP theRAPEUTICS LLC offers a range of technology solutions for vaccines without borders. Their clinical trial, the VLPM01 malaria vaccine candidate, aims to evaluate the safety, tolerability, immunogenicity, and experimental efficacy of the vaccine in healthy, malaria-naive adult volunteers. They also provide platform technologies such as surface antigen display, cancer vaccine, interior gene delivery, and native virus modifi
Want to view all employees of this company? Start for free trial.
Research Details
News &Insights
Key People

view 13 associated members

VLP THERAPEUTICS LLC In Short

VLP THERAPEUTICS LLC is a research services company based in Rockville, Maryland, United States, with 13 employees. Specializing in B2B services, the company has revenue of less than $5 million. Their focus is on developing vaccines without borders, aiming to evaluate the safety, tolerance, immunogenicity, and experimental efficacy of VLPM01 in healthy, malaria-naive adult volunteers. The company's research will be conducted at the Walter Reed Army Institute of Research in Silver Spring, Maryland, focusing on evaluating the safety, tolerability, immunogenicity, and experimental efficacy of VLPM01 in healthy, malaria-naive adult volunteers.

...See More

Company Description of VLP THERAPEUTICS LLC

...See More

9700 GREAT SENECA HWY, ROCKVILLE, Maryland, 20850, US

13

Show More

What does VLP THERAPEUTICS LLC offer?

VLP theRAPEUTICS LLC offers a range of technology solutions for vaccines without borders. Their clinical trial, the VLPM01 malaria vaccine candidate, aims to evaluate the safety, tolerability, immunogenicity, and experimental efficacy of the vaccine in healthy, malaria-naive adult volunteers. They also provide platform technologies such as surface antigen display, cancer vaccine, interior gene delivery, and native virus modifi